Provide a defined quality assurance and infrastructure that will allow (in total or in part) |
The manufacture, quality control, storage, release and delivery of ATMPs |
The design and execution of early phase clinical trials with ATMPs |
The interdisciplinary management of toxicities |
The active follow-up of patients treated with ATMPs, |
Interact on both national and EU level |
Should be accredited in terms of process and structure quality by the local competent authority as the basis for a national accreditation |
May apply for the coverage of costs based on their national accreditation at health insurance companies for certain products |
Should be obliged to establish and maintain a network of exchange with other accredited centers to avoid redundancy and excessive consumption of resources |